Pfizer-BioNTech COVID vaccine candidate succeeds in first interim analysis from phase 3 trial
The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90 per…
Recover your password.
A password will be e-mailed to you.
- Advertisement -
Recover your password.
A password will be e-mailed to you.